mTOR regulates protection against a lethal H5N1 influenza infection by modulating the antibody response

被引：0
|
作者：
McGargill, Maureen [1 ]
Keating, Rachael [1 ]
Hertz, Tomer [2 ]
Lukens, John [1 ]
Wehenkel, Marie [1 ]
Harris, Tarsha [1 ]
Edwards, Benjamin [1 ]
McClaren, Jennifer [1 ]
Brown, Scott [1 ]
Surman, Sherri [1 ]
Wilson, Zachary [2 ]
Hurwitz, Julia [1 ]
Chi, Hongbo [1 ]
Doherty, Peter [1 ]
Thomas, Paul [1 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA
来源：
JOURNAL OF IMMUNOLOGY | 2013年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P6184
引用
收藏
页数：1
相关论文
共 50 条
  • [1] mTOR regulates protection against lethal H5N1 influenza infection by modulating the antibody response
    McGargill, Maureen
    Keating, Rachael
    Hertz, Tomer
    Wehenkel, Marie
    Harris, Tarsha
    Edwards, Benjamin
    McClaren, Jennifer
    Brown, Scott
    Surman, Sherri
    Wilson, Zachary
    Bradley, Philip
    Hurwitz, Julia
    Chi, Hongbo
    Doherty, Peter
    Thomas, Paul
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [2] Protection of cats against lethal influenza H5N1 challenge infection
    Vahlenkamp, Thomas W.
    Harder, Timm C.
    Giese, Matthias
    Lin, Fengsheng
    Teifke, Jens P.
    Klopfleisch, Robert
    Hoffmann, Ralf
    Tarpey, Ian
    Beer, Martin
    Mettenleiter, Thomas C.
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 968 - 974
  • [3] Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection
    Salomon, Rachelle
    Hoffmann, Erich
    Webster, Robert G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (30) : 12479 - 12481
  • [4] Oseltamivir protects ferrets against lethal H5n1 influenza virus infection
    Govorkova, EA
    Ilyushina, NA
    Smith, J
    Webster, RG
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A29 - A29
  • [5] Infection with H9N2 influenza viruses confers immunity against lethal H5N1 infection
    O'Neill, E
    Seo, SH
    Woodland, DL
    Shortridge, KF
    Webster, RG
    OPTIONS FOR THE CONTROL OF INFLUENZA IV, 2001, 1219 : 775 - 781
  • [6] Kinetics and Longevity of Antibody Response to Influenza A H5N1 Virus Infection in Humans
    Kitphati, Rungrueng
    Pooruk, Phisanu
    Lerdsamran, Hatairat
    Poosuwan, Siriwan
    Louisirirotchanakul, Suda
    Auewarakul, Prasert
    Chokphaibulkit, Kulkanya
    Noisumdaeng, Pirom
    Sawanpanyalert, Pathom
    Puthavathana, Pilaipan
    CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (07) : 978 - 981
  • [7] ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus
    Rimmelzwaan, GF
    Claas, ECJ
    van Amerongen, G
    de Jong, JC
    Osterhaus, ADME
    VACCINE, 1999, 17 (11-12) : 1355 - 1358
  • [8] A model for early onset of protection against lethal challenge with highly pathogenic H5N1 influenza virus
    Roehrs, Susanne
    Kalthoff, Donata
    Beer, Martin
    VACCINE, 2014, 32 (22) : 2631 - 2636
  • [9] Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
    Baras, Benoit
    Stittelaar, Koert J.
    Simon, James H.
    Thoolen, Robert J. M. M.
    Mossman, Sally P.
    Pistoor, Frank H. M.
    van Amerongen, Geert
    Wettendorff, Martine A.
    Hanon, Emmanuel
    Osterhaus, Albert D. M. E.
    PLOS ONE, 2008, 3 (01):
  • [10] Protection from avian influenza H5N1 virus infection with antibody-impregnated filters
    Kamiyama, Yoichiro
    Adachi, Kazuhide
    Handharyani, Ekowati
    Soejoedono, Retno Damajanti
    Kusano, Takayuki
    Inai, Marie
    Tsukamoto, Masaya
    Kashiwagi, Seizaburo
    Tsukamoto, Yasuhiro
    VIROLOGY JOURNAL, 2011, 8
12345